FRESENIUS SE+CO.KGAA O.N./ DE0005785604 /
5/9/2025 5:25:30 PM | Chg. +0.180 | Volume | Bid9:59:47 PM | Ask9:59:47 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
43.150EUR | +0.42% | 1,500 Turnover: 63,795 |
-Bid Size: - | -Ask Size: - | 24.31 bill.EUR | 2.32% | 51.38 |
GlobeNewswire
3/18
Leading Academic and Manufacturing Organizations Join Ori Biotech’s Preferred Partner Network to Acc...
GlobeNewswire
4/23/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil